PolyPid Provides Corporate Update and Reports Third Quarter 2024 Financial Results
Last Patient Enrolled for Planned Unblinded Interim Analysis in Ongoing SHIELD II Phase 3 Trial of D-PLEX100 Unblinded Interim Analysis Outcome ...
Lyra Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Company continues to focus on upcoming results from ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients expected in 2Q 2025 Company reports topline ...
TAG24 NEWS on MSN2m
Can a chemical in red wine prevent bowel cancer?
Scientists will explore if a chemical mostly found in red grapes – and products made from red grapes, such as wine and juice – can help prevent bowel cancer as part of a major new trial.The study – ...
Natera, Inc. (NASDAQ:NTRA) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Welcome to Natera’s 2024 Third Quarter Financial Results ...